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ABSTRACT

Two model oxepins were synthesized in an attempt to model the metabolism of benzene
in the human liver. 4,5-Benzoxepin was subjected to similar enzyme reactions that the oxepin
metabolite itself would encounter if one was exposed to benzene. In addition, a synthesis of 2,3benzoxepin was completed in order to compare enzyme and non-enzyme catalyzed reactions
with that of 4,5-benzoxepin. In an attempt to test the validity of the enzyme reactions, the model
oxepins were also reacted with a two single electron oxidizing inorganic salt, cerium (IV)
ammonium nitrate (CAN) to see if the intermediates following the enzyme reaction were
consistent. Other chemists in the past have postulated that oxepin undergoes further epoxidation
in metabolism instead of two single electron oxidations, so a test with dimethyldioxirane
(DMDO) was also performed on the model oxepins to observe if their products closer matched
the enzyme reactions. Research suggests that oxepin can follow both the two single electron
oxidation and further epoxidation metabolic pathways when exposed to enzymes CYP1A2 and
CYP3A4 under multiple concentrations of enzyme with a fixed concentration of model oxepin
substrate.
Keywords: 1-benzoxepin, 2,3-benzoxepin, 3-benxoxepin, 4,5-benzoxepin, benzene
metabolism, oxepin, cytochrome P450, isoform 1A2, isoform 3A4, isoform 2E1, pHLM

Figure 1. Benzene Metabolism via cytochrome P450 oxidation. Some possible products are
phenol (left) and E,E-muconic acid (right).
xi

Amides and lactams are common structural motifs found in a variety of natural products
and construct the backbone of amino acid chains, proteins, and enzymes. Amides have 3 major
resonance contributors (see Figure 2). 4-Silatranones have been calculated previously to have
the nitrogen lone pair delocalized like in normal amides vs. having a coordinate covalent bond
with silicon as in silatranes, which is a bridged bicyclic amine dependent upon conformation.
This research aims to synthesize strained lactams known as 4-silatranones (Figure 3) and to help
elucidate who wins the competition for nitrogen’s lone pair-the silicon via dative bond or
delocalization into the amide carbonyl.
Keywords: Silatranone, strained lactams, amide resonance, silacyclobutane

Figure 2. Resonance forms of amides and lactams.

Figure 3. Novel synthetic approach toward silatranone derivatives via strained silacyclobutane.
Note: IUPAC name for structure shown: 1-propyl-2,8,9-trioxa-5-aza-1silabicyclo[3.3.3]undecane-4-one

Iron chelators have many biological applications including the treatment of iron overload
disease, the suppression or promotion of reactive oxygen species production and even the ability

xii

to sense the iron status in the cell. Development of a chelator that can modulate and sense
intracellular iron is the goal of this research. 8-hydroxyquinoline has been shown as a powerful
chelating agent for iron in the past when three equivalents of 8-hydroxyquinoline have been
tethered to a tripodal linker allowing for a hexadentate chelator to completely sequester iron.
This portion of the project focuses on the synthesis of a tripodal linker with a carboxylic acid
handle (Figure 4) to attach the chelator to lysine residue of a SS-peptide (synthesized by a
research group member) that targets the mitochondria of a cell which contain labile iron pools.
Keywords: Tripodal linker, tripodal chelator, hexadentate chelator, chelation therapy,
SS-peptide, 8-hydroxyquinoline, 7-carboxy-8-hydroxyquinoline, iron metabolism, bifunctional
iron chelator.

Figure 4. Target molecule for sensing and sequestering intracellular iron. Mitochondria
targeting peptide with fluorescent sensor shown in black, 7-carboxy-8-hydroxyquinoline
pendants shown in green, and triamine tripodal linker with carboxylic acid handle shown in blue
(target portion of this research).
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GENERAL INTRODUCTION

This thesis is divided into six chapters: 1) Synthesis of model oxepin substrates for comparative
two electron oxidation studies with enzymes and cerium ammonium nitrate to investigate benzene
metabolism; 2) Synthesis of 2,3-benzoxepin for comparative enzymatic and oxidation studies using
cytochrome P450, mCPBA, and cerium ammonium nitrate; 3) Attempted synthesis of 4-silatranone
derivatives via strained silacyclobutanes; 4) Synthesis of five related amides to measure the effect of
hydrogen bonding on amide rotational barriers; 5) Synthesis of a bifunctional iron(II)/iron(III)
hexadentate 8-hydroxyquinoline based chelator scaffold; 6) Experimental Section. Chapter one contains
an introduction, results and discussion, and conclusions sections of the exploration of oxepin route
benzene metabolism modeled by 4,5-benzoxepin with potential work that could be performed on other
model substrates. Chapter two details oxidation testing on another model oxepin substrate-2,3benzoxepin. Chapter three shows attempts at a novel synthesis of 4-silatranone lactams. Chapter four
shows the variable temperature NMR studies on five related amides to measure amide rotational
barriers. Chapter fives entails the synthesis of a linker scaffold for attaching a hexadentate iron (II)/(III)
chelator to a mitochondria targeting peptide. Chapter six contains relevant experimental details to
support the results revealed in chapters one-five.
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Chapter 1

Synthesis of Model Oxepin Substrates for Comparative Two Electron Oxidation Studies
with Cytochrome P450 and Cerium Ammonium Nitrate to Investigate Benzene
Metabolism

Introduction

Benzene is a known carcinogen and toxic chemical used in industry and as an industrial
byproduct.1,3-7 Knowing the mechanistic pathways which potential toxin substances break down
in the body is useful to prevent illnesses and help those ailing presently.1,3-7 The hypothesis by
Davies and Whitham that epoxidation of oxepin to a reactive 2,3-epoxyoxepin intermediate
furnished the major focus for this study.2 Oxepin derivatives are, therefore, useful models in
investigating the ring opening mechanism of oxepin as postulated in benzene metabolism.2-7
4,5-Benzoxepin (aka. 3-benzoxepin) is a good substrate for use in enzymatic oxidation studies
with cytochrome P450.25,26,28 This project focuses on improving the synthesis of 4,5benzoxepin for use in enzymatic reactions by the Greenberg research group at UNH to establish
the eukaryotic metabolic, ring-opening pathway of benzene and adding a new trial substrate in
2,3-benzoxepin (discussed in chapter 2) to further reveal how oxepin derivatives react when
exposed to enzymes.2,30,45,46
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Figure 1.1. Davies and Whitham proposed mechanism of benzene metabolism towards E,Emuconaldehyde/E,E-muconic acid via a 2,3-epoxyoxepin thermal rearrangement tested by
Golding and coworkers and observed by Greenberg and coworkers in the present study2,48

Figure 1.2. Golding and coworkers proposed mechanism of benzene metabolism towards E,Emuconaldehyde/E,E-muconic acid via consecutive one electron oxidation29
Investigation of benzene metabolism via the oxepin route goes back several decades.
Vogel and coworkers demonstrated that benzene is first epoxidized to benzene oxide and
undergoes a rapid valence tautomerization with oxepin in 1967.1 In 1977 Davies and Whitham
postulated that the oxepin intermediate may undergo further epoxidation via a 2,3-epoxyoxepin
intermediate followed by thermal rearrangement to Z,Z-muconaldehyde and isomerization to
E,E-muconaldehyde/E,E-muconic acid (via aldehyde dehydrogenase).2 In 1982 Tochtermann
and coworkers observed a stable 2,3-epoxyoxepin via epoxidation of an alkyl bridged oxepin.24
In 1997 Golding and coworkers observed Z,Z-muconaldehyde and a ring closed
pyrancarboxaldehyde of muconaldehyde after DMDO low temperature epoxidation of oxepin
but were unable to observe the 2,3-epoxyoxepin intermediate via their methods.27 Greenberg
and coworkers observed a simple 2,3-epoxyoxepin via low temperature NMR oxidation of 2,7dimethyloxepin which rearranges to a diketone structure upon gentle heating in 1998.26 In
3

2010, Golding and coworkers suggested that oxepin could ring open via a consecutive single
electron oxidation (two electrons removed from oxepin total) mechanism via tests with Ce4+
and Fe3+ yielding muconaldehyde isomers.29 Finally, in 2020, we published our GC/MS
findings of cytochrome P450 oxidation with that of cerium (IV) ammonium nitrate (CAN) and
dimethyldioxirane (DMDO) showing evidence for both mechanisms.48
Benzene metabolism via the oxepin route can be studied through the synthesis of model
substrates containing a derivate of oxepin. The two studied were: 2,3-benzoxepin and 4,5benzoxepin. Synthesis of 2,3-benzoxepin and synthesis of 4,5-benzoxepin have been completed
and tested. The two model substrates can be made through multistep syntheses and can further
be employed in enzymatic reactions and two electron oxidations with CAN. Scheme 1.1 and
Scheme 1.2 show the two synthetic routes toward model oxepin 4,5-benzoxepin.
4,5-Benzoxepin had been earlier reacted with dimethyldioxirane leading to the
observable 2,3-epoxyoxepin at low temperatures by our group.25 Subsequently reacted with
cerium (IV) ammonium nitrate which resulted in dimeric products (this work).48 To further
validate this dimer, a synthesis of a dibenzodimer derivative synthesis was performed and can
be seen via Scheme 1.3.
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Scheme 1.1: Multistep synthesis of 4,5-benzoxepin.48

Scheme 1.2: Photochemical synthetic route towards 4,5-benzoxepin.48

5

Scheme 1.3: Synthesis of dibenzodimer comparison.48

Results and discussion

4,5-Benzoxepin was the target model oxepin in this study and can be obtained via two
different synthetic pathways. The original multistep synthesis involved starting with
naphthalene (1-1) as the building block molecule. Naphthalene (1-1) first underwent a Birch
reduction using sodium metal in liquid ammonium to yield 1,4-dihydronaphthalene (1-2). 1,4dihydronaphthalene (1-2) has a free alkene not conjugated into the aromatic system which can
be epoxidized using mCPBA to yield epoxide (1-3). Epoxide (1-3) is then subjected to benzylic
bromination via NBS (N-bromosuccinimide) to install a good leaving group and to afford
brominated epoxide (1-4). Brominated epoxide (1-4) can be converted to 4,5-benzoxepin (1-5)
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via a dehydrohalogenation reaction using potassium t-butoxide as the hindered base. The
mechanism for dehydrohalogenation is shown in Figure 1.3 below.48

Figure 1.3. Dehydrohalogenation to form 4,5-benzoxepin.1,48
An alternative synthesis for 4,5-benzoxepin (1-5) was developed that was more
succinct involving only two steps (Scheme 1.2). Anthranilic acid (1-8) proved to be a highly
useful synthon as it allowed for in situ generation of benzyne which can undergo a Diels-Alder
reaction with furan to yield bridged oxide (1-9). When dilute 1-9 was exposed to 254nm light
in absolute ethanol, it afforded 4,5-benzoxepin (1-5) in approximately 10% yields after silica
column to remove 82% 1-napthol byproduct.
4,5-benzoxepin (1-5) was subjected to epoxidation conditions using dimethyldioxirane
by former Greenberg group members Jessica Morgan and Holly Guevara so it did not require
repeat experiments as it afforded 1H-2-benzopyran-1-carboxaldehyde (1-6) product each time
completed presumably via ring opened di-aldehyde and 2,3-epoxyoxepin intermediates as
shown in Figure 1.4 to study the further epoxidation mechanism of oxepin.25

7

Figure 1.4. Nauduri’s observation of 1H-2-benzopyran-1-carboxaldehyde presumably via a
2,3-epoxyoxepin and di-aldehyde intermediates.25
4,5-benzoxepin (1-5) was tested for consecutive single electron oxidation mechanism by
using two equivalents of cerium (IV) ammonium nitrate (CAN) in the presence adventitious
water from the solvent, acetone.29 The two major products of the CAN reaction are known as
“fraction 1” (1-7) and “fraction 2” (1-10) due to their fraction appearance upon silica flash
chromatography. NMR experiments using deuterated acetone and excess CAN showed that 1-7
does not turn into 1-10 or vice versa over time. Dimeric product 1-7 was proposed by the group
because of the integrations on the 1H NMR (H=7), number of unique carbons (C=10), presence
of ketone C=O on IR at 1666 cm-1, and absence of O-H on IR. 2D NMR shows no coupling of
the C-H proton of the dimeric linkage to other protons on the structure (via COSY) and no
through space interactions (via NOESY). This led our group to the conclusion that there is a CC bond in a dimeric fashion. Unfortunately, upon electron impact mass spectrometry analysis,
dimer 1-7 appeared to decompose into isocoumarin with a mass/charge of 146 m/z. A potential
mechanism for this breakdown is shown in Figure 1.5.48
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Figure 1.5. Potential mechanism of breakdown of dimer 1-7 into isocoumarin with 146 m/z and
174 m/z peaks via Electron Impact Mass Spectrometry.
An attempt to validate the structure of dimer 1-7 (“fraction 1”) was undertaken. This
was attempted by synthesis of bromo-dibenzo monomer 1-14 and attempted nickel
homocoupling for two alkyl bromide sp3 carbon centers. 1-13 had been made previously in the
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literature so we brominated it selectively with NBS and ammonium acetate to afford 1-14. 1-13
can be made in two steps starting with building block 2-phenylphenol (1-11). 1-11 can be
alkylated with 2-bromoacetic acid ethyl ester and base/acid work ups to yield the carboxylic
acid derivative 1-12. Acid 1-12 can be cyclized using strong acid trifluoroacetic acid with
trifluoroacetic anhydride into 1-13. Enough 1-14 was synthesized by former group member Dr.
Holly Guevara to allow testing. An unexpected and puzzling observation was the formation
benzoisocoumarin (1-16) rather than dimeric 1-15 (see Scheme 1.3). Where did the two CH
groups go? Were they simply eliminated as acetylene? This suggested investigating analysis of
the headspace in the reaction vessel. With assistance of the equipment in the Gonghu Li lab at
UNH, the coupling reaction was tested out in a test tube under argon and the headspace gas
identified via syringe removal and GC analysis. Surprisingly, the headspace appeared to
indicate methane as the gaseous byproduct even as 1H NMR showed the same rearrangement
product that Dr. Guevara had found to be benzoisocoumarin (1-16) with no isolation of dimer
1-15 at all. We were hoping to isolate the dibenzodimer to validate our dimer findings but it
was very interesting and promising to see a similar rearrangement akin to what was shown on
the mass spec with “fraction 1” and its potential breakdown to a 146m/z isocoumarin (Figure
1.5). At this time, the mechanism for the formation of benzoisocoumarin (1-16) through the
seeming thermal decomposition of expected product 1-15 (Scheme 1.3) and the observation of
isocoumarin (146 m/z) in the EI mass spectrum of the homologue dimer 1-7 (see Figure 1.5).
Figure 1.6a shows the proposed mechanism for the formation of dimeric product “fraction 1”
1-7 and major product “fraction 2” dimer 1-10 has its mechanism shown in Figure 1.6b.
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Figure 1.6a. Proposed mechanism for the formation of “fraction 1” dimer 1-7.48

11

Figure 1.6b. Proposed mechanism for the formation of “fraction 2”dimer 1-10.48
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Enzymatic oxidation was tested on 4,5-benzoxepin (1-5) using cytochrome P450
isoforms 2E1 (smaller active site isoform known to metabolize benzene), 1A2 (known to
metabolize naphthalene which is of similar size to 1-5), 3A4 (larger active site able to
metabolize a myriad of substrates), and pHLM (pooled human liver microsomes).45 In nearly a
3:1 ratio 1H-2-benzopyran-1-carboxaldehyde (1-6):“fraction 1” (1-7) shows that cytochrome
P450 appears to follow both epoxidation and consecutive single electron oxidation
mechanisms. A typical enzyme protocol is shown in Figure 1.7 and all reactions were diluted
to correct concentration and 1mL reaction volume with MilliQ water.
Enzyme

Substrate

[Substrate]

[Enzyme]

[NADPH]

[MgCl2]

2E1
4,5-benzoxepin
300 μM
50 pmol/mL
1.0 mM
3.3 mM
1A2
4,5-benzoxepin
300 μM
35 pmol/mL
1.0 mM
4.4 mM*
3A4
4,5-benzoxepin
300 μM
35 pmol/mL
1.0 mM
3.3 mM
pHLM 4,5-benzoxepin
300 μM
0.5 mg/mL
1.0 mM
3.3 mM
Figure 1.7. Typical enzyme reaction protocol. *Optimized amount-complete substrate
consumption.48
A series of organic syntheses and enzymatic reactions were run and improved. Every
step of the 4,5-benzoxepin synthesis now has a satisfactory yield. The free radical bromination
improved to a 64% yield from 9.81% in past reactions, which significantly improved the
multistep synthesis productivity. Epoxide starting material from that reaction was recovered
from column chromatography and was reused. An aprotic solvent was used with carbon
tetrachloride instead of dichloromethane and also AIBN was used instead of benzoyl peroxide
with light as an initiator instead of heat and now yields are regularly 60% or better. To improve
the dehydrohalogenation of brominated epoxide to 4,5-benzoxepin, a few simple changes were
made. Diethyl ether was replaced with dry THF because potassium t-butoxide is more soluble
in it and 4 equivalents of potassium t-butoxide were also used. Along with these two minor
changes the apparatus was changed as well. Originally, a solid addition of potassium t-butoxide
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was done to brominated epoxide stirring in the flask. In the second attempt, the potassium tbutoxide was placed in the flask to stir to improve solubility and the brominated epoxide
(dissolved in THF) was added drop wise through a dropper funnel and all of these
improvements helped ensure that all reactants were in the same phase to react.
Studies were completed on the metabolism of 4,5-benzoxepin, benzene, and
naphthalene. A reaction was performed on benzene as a control reaction to test enzyme purity
and effectiveness. This reaction did not work, but it provided invaluable experience in
enzymatic reactions. Two different reactions with 4,5-benzoxepin with enzymes or CAN
yielded promising results but required further analysis and purification at the time. The
enzymatic reactions may require further concentration adjustments, but a lower limit of
substrate concentration has been established due to low concentration reactions with enzymes
1A2 and pHLM. The enzyme reactions worked more optimally due to the addition of excess
Mg2+ (4 equivalents consumed all starting materials) to the system for naphthalene and 4,5benzoxepin metabolism with enzyme isoform 1A2 or 3A4. Product 1-6 and the “fraction 1”
product (1-7) have been shown in small concentrations in the GCMS chromatograms (see
Figure 1.8) when compared to their standard samples.
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Figure 1.8. A) Total Ion Chromatogram (TIC) for reaction of 4,5-benzoxepin 1-5 with P450 1A2;
B) Mass spectra of compounds 1-5, 1-6, and “fraction 1” 1-7 products, respectively
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General conclusions

An attempt to elucidate the mechanism of benzene to ring opened metabolite Z,Zmuconaldehyde/Z,Z-muconic acid via cytochrome P450 was undertaken. This research aimed to
determine if oxepin metabolized via a 2,3-epoxyoxepin or radical cation/two electron oxidation
mechanism. Model oxepin substrate 4,5-benzoxepin was the focus of this research and it
afforded evidence of 2,3-epoxyoxepin via low temperature NMR using DMDO by prior group
members (Nauduri) as well as promising dimeric products that underwent rearrangement when
exposed to cerium (IV) ammonium nitrate as the electron oxidizing agent. P450 studies were
introduced with this project-researchers (Golding et. al and Davies et. al.) in the past have
postulated these mechanisms but were missing the actual enzyme data for comparison. Various
P450 isoforms yielded a mixture of the product of the DMDO epoxidation and CAN consecutive
single electron oxidation providing some evidence that both mechanisms are in play.
Optimizations of the enzyme protocol were also performed and when four equivalents of MgCl2
were used relative to the NADPH and glucose-6-phosphate, all of the substrate was able to be
consumed by the P450 enzyme isoform.
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Chapter 2
Synthesis of 2,3-benzoxepin for comparative enzymatic and oxidation studies using
Cytochrome P450, mCPBA, and Cerium Ammonium Nitrate

Introduction

The 4,5-benzoxepin project provided the inspiration for oxidation studies on other
oxepins. Dr. Holly Guevara of the Greenberg group did both enzyme, epoxidation, and two
electron oxidation reactions on 2,7-dimethyloxepin which localizes the carbocation on the
tertiary carbon adjacent to the oxygen as Golding and coworkers proposed would occur upon
reaction with CAN making it an excellent model oxepin.2,29,48 This project spawned from the 4,5benzoxepin and 2,7-dimethyloxepin substrates as another way to find out if competitive
enzymatic epoxidation would occur in an oxepin at the 2,3-olefinic or 4,5-olefinic positions as
shown in Figure 2.1.48-51 This project also set out to set if similar dimeric products will form
when exposed to CAN and enzymes as with the 4,5-benzoxepin project. As shown in Figure 2.1,
4,5-benzoxepin (1-5) only contains a 2,3 functionalizable olefin without breaking aromaticity of
the benzene ring whereas 2,3-benzoxepin (aka. 1-benzoxepin, 2-7) contains both a free 4,5olefinic group and a 2,3-olefinic group akin to that of an oxepin intermediate metabolite.48
Enzymatic testing on 2,3-benzoxepin would serve as a means to further complete out knowledge
on the epoxidation and consecutive two electron oxidation of oxepin intermediates.
The synthesis of 2,3-benzoxepin (2-7) is outlined in Scheme 2.1 (multistep) and Scheme
2.2 (one-pot synthesis). Further reactions of 2,3-benzoxepin with consecutive two electron
oxidizing agent CAN, epoxidizing agent mCPBA, and enzyme cytochrome P450 isoform 1A2
are shown in Scheme 2.3.
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A.)

B.)
Figure 2.1. A.) Past group member’s model oxepin 2,7-dimethyloxepin. B.) Versatility of 2,3benzoxepin as a model oxepin substrate

Scheme 2.1: Attempted multistep synthesis of 2,3-benzoxepin
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Scheme 2.2: Single step synthesis of 2,3-benzoxepin via in situ benzyne generation

Scheme 2.3: Comparison of model oxepin substrate 2,3-benzoxepin reaction with cytochrome
P450 isoform 1A2 vs. reactions with CAN and mCPBA
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Results and discussion

An attempt to synthesize model intermediate metabolite 2,3-benzoxepin (2-7) was
underwent. The multistep synthesis shown in Scheme 2.1 ended with a mixture of mono- and
dibrominated dihydrobenzoxepins. The original synthesis involved an o-allylation of 2allylphenol (2-8) followed by ring-closing metathesis of 1-allyloxy-2-allylbenzene (2-9) to afford
2,5-dihydro-1-benzoxepin (2-10) as the oxepin framework.48-50 Relocation of the double bond
was required to generate 2,3-benzoxepin (2-7) and was attempted to be done via NBS
monohalogenation and subsequent dehydrohalogenation. Preliminary mass spec data done by the
Anyin Li group at UNH showed the presence of both monobrominated products 2-12a and 2-12b
as well as a dibrominated product (2-12c). It was decided that this mixture of products would
make dehydrohalogenation difficult, so it was not attempted.
A new approach for the synthesis of 2,3-benzoxepin was attempted inspired by the 4,5benzoxepin synthesis involving a benzyne Diels-Alder reaction. Anthranilic acid (1-8) can be
used to generate benzyne in situ when combined with isopentyl nitrite because it transforms the
Ar-NH2 substituent into a diazonium Ar-N2+ leaving group. Subsequent deprotonation of the ArCO2H group sets off elimination of CO2 and N2 as gases leaving a triple bond in their place
which is shown in Figure 2.2. This newly generated benzyne can be combined with pyridazine
N-oxide to form 2,3-benzoxepin in a one-pot reaction.

Figure 2.2. In situ generation of benzyne from anthranilic acid

20

A reaction with cerium (IV) ammonium nitrate and mCPBA were tested on 2,3benzoxepin. The mCPBA reaction appears to yield mono-hydroxylated products as shown by the
two doublet and two singlet patterns in the NMR shown in Figure 2.3. Integrations of the
singlets come out to 1H and 1H leading to the enol assignment for the structure vs the keto
tautomer. The CAN reaction tells a similar story appearing to yield a monohydroxylated enol in
equilibrium with its keto tautomer as seen in Figure 2.3.
2,3-benzoxepin was also tested with cytochrome P450 isoform 1A2 (CYP1A2) and the
products were analyzed via electron impact mass spectrometry. The reaction appeared to yield 3
monohydroxylated species as shown by the three 162-163 m/z peaks shown in chromatograms in
Figure 2.4. There were also 3 similar retention time GC peaks further supporting this
conclusion. Also, as a very minor product with retention time of 20.29 minutes was a potential
dimeric product with a 318 m/z ratio that was elusive in the 4,5-benzoxepin project for “fraction
1” dimeric product 1-7.
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A.)

B.)
Figure 2.3. 1H NMR of the A.) mCPBA reaction with 2,3-benzoxepin and B.) the CAN reaction
with 2,3-benzoxepin
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Figure 2.4. Electron impact mass spectra of CYP1A2 reaction with 2,3-benzoxepin
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General conclusions

An attempt to add another model oxepin substrate to our mechanistic studies of
cytochrome P450 was undertaken. Our one-pot synthesis of the model substrate 2,3-benzoxepin
proved to be very effective but also expensive because the high cost of pyridazine N-oxide
limited the quantity of 2,3-benzoxepin synthesized. The multistep synthesis had excellent yields
up to the bromination step by either Br2 or NBS which caused the major shift in synthetic
strategy. The 2,3-benzoxepin project was completed but purification was challenging due to the
small scale of the mCPBA and CAN reactions. Each reaction had changes in the proton NMR
but both did not yield enough material for adequate carbon NMR making identification difficult.
The enzyme reactions were more successful with excellent signal to noise on the GC trace and 3
clear peaks with chromatograms of 162 M/Z indicative of monohydroxylations in three different
locations.

24

Chapter 3
Attempted synthesis of 4-silatranone lactam derivatives via strained silacyclobutanes

Introduction

Strained lactams and amides have been an area of interest for Greenberg and coworkers
for years. Dr. Jessica Morgan synthesized several strained lactams as well as carrying out the
computational aspects of silatranes with amide linkages (Figure 3.1).52,53,59 Former
undergraduate Azaline Dunlap-Smith did an honors thesis on the computational aspects of both
silatranes and silatranones derivatized at the 1-position (off the silicon) that helped pave the way
for this synthesis project.52,58

Figure 3.1. Left: Silatrane derivatives computationally analyzed by Azaline Dunlop-Smith and
synthesized in this work; Right: 1-methyl-4-silatranone, a target molecule of this work
Silatranes come from a family of molecules called atranes which contain three 5membered rings in a bridged tricyclic fashion.52,56-58,60-62 A silatrane itself is a bridged tricyclic
amine whereas a 4-silatranone is the presently unknown lactam derivative of a silatrane.52,56-58
Silatranes were first discovered by Frye and coworkers as white solid mixed within polymeric
material.52,56 3-Silatranones have been made in the past to make the ester/lactone.58,60-61 A 4silatranone provides a lot of molecular complexity and challenge to synthesize because it may
change the geometry of the nitrogen to planar and can delocalize the lone pair which normally
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stabilizes a silatrane and locks it together with a tetrahedral nitrogen and bipyramidal silicon via
a dative/coordinate covalent bond.52,58
This work set out to improve the access of silatrane derivatives via rotary evaporator
(rotovap) synthesis and hopefully uncover the first synthesis of a 4-silatranone (Scheme 3.1)
either by conventional reflux methods or the rotovap approach used for silatranes.

Scheme 3.1: Attempted syntheses of novel silatranone lactam derivatives 3-7 and 3-9
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Scheme 3.2: Quantitative synthesis of 1-methylsilatrane

Results and discussion

Two multistep syntheses were explored in an attempt to synthesize the novel silatranone
lactams 1-methyl-4-silatranone (3-9) and 1-propyl-4-silatranone (3-7). GC/MS analysis suggests
promising but inconclusive data for the synthesis of the methyl derivative alongside oligomeric
polysiloxane byproducts. The propyl derivative was less successful but the 1,1dichlorosilacyclobutane (3-6) provides energy to aid in overcoming the uphill, endergonic barrier
(21 kcal/mol calculated via B3LYP/6-31G*) to forming the desired 4-silatranone in the form of
releasing ring strain (26 kcal/mol).33
Both 1-methyl-4-silatranone and 1-propyl-4-silatranone required the synthesis of the
tertiary amide, N-glycolyldiethanolamine (3-5), as a building block to serve as the top of the
lactam structure. This amide can be obtained via a two-step synthesis. The first step entails the
acetal protection of acetone using glycolic acid as the source of a diol to afford 2,2-dimethyl-1,3dioxolan-4-one (3-3, aka. glycolic acid acetonide). Successful synthesis of 2,2-dimethyl-1,3dioxolan-4-one (3-3) could only be achieved with the addition of P2O5 as a drying agent because
the reaction is completely reversible, and any trace water would give clear, white solid glycolic

27

acid precipitate in the flask. This lactone serves as a glycolic acid donor when reacted
diethanolamine (3-5) in the next step with acetone as the byproduct. This is an advantageous
byproduct because reduced pressure in the form of the rotary evaporator can help drive the
reaction to completion by removal of acetone. Silica column using two polar eluents (4:1
Methanol:ethyl acetate) gave good yields of the desired amide.
N-glycolyldiethanolamine (3-5) can then be reacted with triethoxymethylsilane (3-8) via
three nucleophilic substitutions of the three primary alcohols of the amide and three successive
deprotonations by the ethoxide leaving groups to generate the desired lactam and three
equivalents of ethanol. This proved to be a very challenging reaction. Excessive heating or
moisture promoted the formation of polysiloxane polymers forming networks/gels to
immediately precipitated out of solution. Figure 3.2 and Figure 3.3 show the most promising
NMR data for synthetic attempts for 1-methyl-4-silatranone. Figure 3.4 shows the GC/MS total
ion chromatogram and mass spectrum showing a mass/charge ratio of 202 m/z short of the 203
g/mol of 1-methyl-4-silatranone (3-9), which is potentially due to an instrument calibration issue.
While this is promising, the results should be interpreted with caution. There is potential that 1methyl-4-silatranone was synthesized and it lost a proton in the electron impact mass spec
process. Similar systems containing a methylene alpha to both an ether and amide carbonyl have
been calculated to have a pKa of -0.77, which is very easily deprotonated. At this time, we
believe that it is unlikely that the methyl derivative was made successfully but these results were
promising.
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Figure 3.2. 1H NMR of potential 1-methyl-4-silatranone in a 1:1 mix of CDCl3 and CD3OD.
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ED

Figure 3.3. 1H-1H COSY NMR of potential 1-methyl-4-silatranone in a 1:1 mix of CDCl3 and
CD3OD.
1-propyl-4-silatranone (3-7) has been more elusive with NMR peaks for the alkyl chain
integrating much higher than it should indicative of polysiloxane oligomer formation. This was
not unexpected however, the 1,1-dichlorosilacyclobutane starting material was very reactive and
could be seen fuming as soon as the cap of the bottle was removed. Preliminary electron impact
mass spec showed only high molecular weight oligomer formation, but the reactivity of this
reagent shows promise towards generating a strained molecule in the form of a n-propyl-4silatranone.
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Figure 3.4. Electron impact mass spectrum of reaction towards 1-methyl-4-silatranone
General conclusions

Strides have been made towards a successful synthesis of a novel 4-silatranone derivative
with a mass to charge of 202 m/z appearing on electron impact mass spec potentially of a
deprotonated 1-methyl-4-silatranone. Attempts to synthesize the n-propyl derivative continue to
provide polymers and gel networks, but the added reactivity of silacyclobutanes is a very
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tempting synthesis avenue. The rotovap synthetic method for generating 1-methylsilatrane is
very efficient and viable for synthesizing 4-silatranones as well but there are so many conditions
to consider (eg. heating, when to lower pressure, how to prevent polymerization). Stirring a room
temperature and gradually heating to reflux over the course of a few days was not effective.
There is a possibility that there is a better silane starting material that we have not consider as
well. Ultimately this project has left us with far more questions than answers but the low pKa of
methylene protons alpha to the lactam carbonyl could a source of confusion about the success of
the synthesis of the methyl derivative.
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Chapter 4
Synthesis of five related amides to measure the effect of hydrogen bonding on amide
rotational barriers

Introduction

The questions that arose from the 4-silatranone project provided a desire for more knowledge on
the amide starting materials.52,55 N-glycolyldiethanolamine (3-5) has a uniquely lower carbonyl
frequency of 1590 cm-1, which we postulated was due to many sources of intramolecular
hydrogen bonding restricting the amide rotation.55 To see if this was the case, related amides
were synthesized and purchased that were lacking terminal OH groups and contained methyl
groups in their place into each possible combination (Figure 4.1).55

Figure 4.1. Five related amides synthesized and purchased for testing amide rotational barriers
and number of hydrogen bond donors/acceptors.55
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Each amide was able to be dissolved in acetonitrile-d3 and tested for their rotational
barrier via variable temperature NMR. The coalescence temperature was measured and this
temperature was used to back calculate ΔGǂ of the rotational barrier using a derivative of the
Eyring equation. This equation (shown in Figure 4.2) also factors in the change in
frequency/chemical shift that occurs in the heating process. The coalescence temperature is
recorded when the two peaks merge and smooth out.
(ΔGǂ / RTc) = (22.96 + ln(Tc / Δν))
For ΔGǂ in kJ/mol with Tc in Kelvin (K) and Δν in Hz.
or:
ΔG‡ = -RT ln (krh/kBTc) = 1.987 Tc (23.06 + ln (Tc/kr))
For ΔGǂ in kcal/mol with Tc in K.
ΔH‡ = -1.9872 (slope)
ΔS‡ = 1.9872 (intercept - ln(κkB/h) (κ = transmission coefficient = 1/2)
ln (κ kB/h) = 23.06 (where κ = ½)
where:
kr = rate constant
Tc = temperature (K)
h = Planck’s constant
kB = Boltzmann constant
R = gas constant (1.987 cal/degC mol)
Figure 4.2. Derivatives of the Eyring equation that relates coalescence temperature (Tc) and
change in chemical shift (in Hz) with transition state Gibbs free energy (ΔGǂ in kJ/mol above or
kcal/mol below).55,76,81
Results and Discussion
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Five related amides were either synthesized or purchased and studied by variable
temperature NMR analysis. Coalescence temperatures were measured and were used to calculate
the ΔGǂ of the amide rotational barrier. N,N-diethylacetamide (4-2) was purchased and used as is
for this experiment. The other four amides were synthesized in an efficient one-step synthesis for
each amide (shown in Scheme 4.1).

Scheme 4.1: One-step syntheses of four of the five related amides. N,N-diethylacetamide (4-2)
was purchased. Glycolic acid acetonide (3-3) was synthesized via the same procedure as in
chapter 3.55,76-81
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Figure 4.3. Variable temperature NMR data for A) 3-5 and B) 3-5 1/10 dilution.55
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Four amides were synthesized in this work. First, N-glycolyldiethanolamine (3-5) was
synthesized via the same approach as in chapter 3-protection of acetone with glycolic acid to
form glycolic acid acetonide (3-3) followed by stirring of diethanolamine (3-4) with the
acetonide to form the desired amide 3-5. Next, N-acetyldiethanolamine (4-1) was synthesized by
combining acetic anhydride (4-5) with diethanolamine (3-4) in a mono-acetylation reaction. Nglycolyldiethylamine (4-3) was generated via SN2 reaction of sodium hydroxide (4-7) with 2bromo-N,N-diethylacetamide (4-6). Finally, N,N-bis[2-(acetyloxy)ethyl]acetamide (4-4) was
created by combining excess acetic anhydride (4-5) with diethanolamine (3-4) in a tri-acetylation
reaction.
Each amide underwent variable temperature NMR (400 MHz) heating to find their
coalescence temperature (Tc) and an example of this is shown in Figure 4.3.
kr (sec-1)

Amide

Protons

Tc (°C)

3-5
3-5
3-5 (1/10 conc)
3-5 (1/10 conc)
4-1
4-1
4-1 (in DMSO)

NCH2
CH2O
NCH2
CH2O
NCH2
CH2O
NCH2

63
63
64
64
35
72
77

6.81
9.01
7.70
14.2
1.21
8.41
25.8

4-1 (in DMSO)

CH2O

77

24.5

4-2
4-2
4-3
4-3
4-4
4-4
4-4

NCH2
CH2CH3
NCH2
CH2CH3
NCH2
CH2O
COCH3

30
74
63
63
70
72
70

(2.5)
34.8
28.9
15.6
20.1
17.6
20.8
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ΔGǂ
(kcal/mol)
18.0
17.8
18.0
17.6
17.5
18.4
17.85
(DMSO)
17.89
(DMSO)
(16.8)
17.5
17.0
17.4
17.7
17.9
17.6

νCO (cm-1)
(neat)
1590

νCO (cm-1)
(CH3CN)
1631

1606

1639

1634

1633

1633

1647

1638

1643

Figure 4.4. Calculated ΔGǂ values (shown in kcal/mol with uncertainty ±0.1-0.2 kcal/mol) from
coalescence temperatures (shown in °C) for the five related amides in this study.55
As shown in Figure 4.4, the ΔGǂ values range from 17.0 kcal/mol to 18.4 kcal/mol,
which does not demonstrate a large change in the rotational barrier despite varying degrees of
hydrogen bonding of the five related amides.55 Amide 4-2 lacks the extra OH groups and has a
ΔGǂ of 17.5 kcal/mol whereas amide 3-5 has the most OH groups/hydrogen bonding ability has
its barrier increase to only 18.0 kcal/mol.55 This culminated in us concluding that hydrogen
bonding is not a major contributor to the amide rotational barriers at least when it comes to these
systems.55
General conclusions
The amide rotational barrier of five related amides was determined to evaluate the
effect/if there was an effect related to intramolecular hydrogen bonding. Variable temperature
NMR in acetonitrile-d3 proved to be an invaluable technique in measuring these rotational
barriers. Intramolecular hydrogen bonding appears to have little to no effect on the amide
rotational barrier resulting in ΔGǂ of only 1.4 kcal/mol in difference at most. Though this might
not be the most interesting result, it helps further complete our knowledge on amides and their
barriers.
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Chapter 5
Synthesis of a bifunctional iron(II)/iron(III) hexadentate
8-hydroxyquinoline-based chelator scaffold

Introduction

Cellular labile iron plays a pivotal role in many biological processes through its role in
the Fenton reaction.66,67,69,75 Strongly bound iron, as in heme, is not Fenton active, but the
intracellular transit of iron involves weakly bound, Fenton-active iron, referred to as the labile
iron pool.66,67,69,75,82 The Fenton reaction (shown in Figure 5.1) is responsible for the generation
of reactive oxygen species (ROS) including hydroxyl radical.69,72,73,75 These reactive oxygen
species can go on to damage cellular components including lipids and DNA.69,72-73,75 In the
ferroptosis process of programmed cell death, oxidized lipids (lipid ROS) are produced.
66,69,72,73,75

Iron chelators can prevent Fenton chemistry.66,68 Labile Fe3+ found in reducing

environments should also be considered as targets for chelation as reduction from Fe3+ to Fe2+
can cascade into the Fenton reaction process.63,66-69,75
This project addresses chelators of use in two areas, the understanding of ferroptosis and
the treatment of iron overload disease.75 Iron overload disease can result in a shortened life span,
decreased quality of life, and increased Fenton chemistry.75 The subject chelator should be
capable of sequestering both iron(II) and iron(III), and be usable in vitro and in vivo for these
purposes. The most important site of intracellular iron metabolism is the mitochondrion.83 By
targeting the chelator to the mitochondria with an appropriate peptide, these two areas are
addressed.66
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Figure 5.1. Fenton chemistry
Great strides have been made towards iron chelators by Serratrice et al. through the use of
catechol chelating pendants on tripodal scaffolds (Figure 5.2).63,66,68 Hider and coworkers made
the same tetrapeptide sequence as ours (Figure 5.2) with a catechol conjugated to the lysine
residue capable of coordinating Fe3+. In order to chelate both Fe2+ and Fe3+ intracellularly, we are
studying 8-hydroxyquinoline-based chelators (Figure 5.2).67 Previous studies of tripodal iron
chelators in our group focused on Fe2+ chelators, namely the tamepyr and tachpyr ligands, which
are based on aminopyridyl pendant groups, and have inspired the current project (Figure
5.2).71,84
Catechol pendants groups are good at chelating the harder acid Fe3+ through phenolic
oxygens and amide carbonyl donors whereas tamepyr and tachpyr ligands chelate through iminopyridyl and amino-pyridyl groups resulting in a higher affinity for the softer acid Fe2+.67,71 8Hydroxyquinoline-chelating pendant groups used in this study offer both a pyridyl nitrogen and
phenolic oxygen to complex iron, and two potential binding modes which bind both Fe(II) and
Fe(III) when tethered by TREN (tris(2-aminoethyl)amine) in a tripodal fashion.66 In this work,
we replace TREN with a new tripod scaffold capable of conjugation to a lysine residue of a
targeting peptide via a carboxylic acid group.66
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Tamepyr

CacCAM

Figure 5.2. Inspiration for the hexadentate iron chelator. Left to right: Hider and coworkers
catecholic peptide design, Planalp and coworkers Fe2+ tamepyr ligand, and Serratrice and
coworkers conjugatable tripodal hexadentate ligand CacCAM for Fe3+.

There are limitations to our three inspirational molecules. Firstly, the Hider and coworkers
tetrapeptide has the ability to target the mitochondria of a cell due to its unique cationic
hydrophobic repeating residues (a member of the Szeto-Schiller peptide family).74 The Hider
molecule also contains the catechol iron chelating pendant which is only selective for Fe3+, thus
cannot fully shut down Fenton chemistry which is driven by the transformation of Fe2+ to Fe3+
via peroxides.67,75 It would also require three equivalents of catechol (a bidentate ligand) and
peptide to coordinate one Fe3+ by filling all six coordination sites. Hexadentate coordination is
achieved by the tamepyr ligand, but the softer nitrogen chelates favor Fe2+ solely so labile Fe3+ in
the mitochondria could still be reduced and participate in Fenton chemistry.71,75 The tamepyr
ligand also lacks a targeting group such as a peptide but one could be feasibly attached in the
future.71 Finally, CacCAM developed by Serratrice and coworkers achieves hexadentate binding
of Fe3+ completely but is not a soft enough ligand to accommodate Fe2+ as well. The 7-carboxy-
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8-hydroxyquinoline pendant ligand attached via amide bonds should, in principle, provide the
happy medium needed to coordinate both Fe3+ and Fe2+.67 It can bind Fe2+ via the pyridyl
nitrogen and phenolic/phenoxide oxygen in a 5-membered chelate and it can bind Fe3+ via
coordination of the amide carbonyl and phenolic/phenoxide oxygens in a 6-membered chelate.67
The outline for the synthesis of this novel hexadentate chelator scaffold is outlined in
Scheme 5.1 including its future prospective attachment to our group’s mitochondria targeting
peptide synthesis via solid phase peptide synthesis by group member Leonid Povolotskiy.66,74
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Scheme 5.1: Synthesis of tripodal hexadentate chelator linked to a mitochondria targeting
tetrapeptide. Mitochondria targeting peptide with fluorescent sensor shown in black, 7-carboxy8-hydroxyquinoline pendants shown in green, and triamine tripodal linker with carboxylic acid
handle shown in blue (target portion of this research).

Results and discussion

The synthesis of a triamine tripodal linker has been completed to this point, with the final step
being amide condensation to chelating pendant group firstly, 7-carboxy-8-hydroxyquinoline.
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Two synthetic steps remain to obtain the peptide conjugate which are a TBS deprotection step
and oxidation of the resulting alcohol to a carboxylic acid, enabling amide condensation of the
ligand to a peptide lysine group.
The triamine ligand scaffold has been prepared by a multistep synthesis. Condensation of
acetaldehyde and cyclohexylamine afforded an imine (5-2) which was subjected to enamine
Michael addition of three equivalents of acrylonitrile, achieved via a pressure reactor at 170
degrees Celsius to overcome the barrier to forming the first tripodal structure (5-3) seen in
Figure 5.3.

Figure 5.3. Synthesis of imine trinitrile/first tripodal structure
This imine trinitrile (5-3) was hydrolyzed into aldehyde trinitrile (5-4) via water and
concentrated HCl and is shown in Figure 5.4. This transformation can also be monitored by 1H
and 13C NMR as the number of peaks drastically reduce to 3 proton NMR signals and 5 carbon
NMR signals.

A.)
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B.)

B.)
Figure 5.4. A.) Imine hydrolysis of imine trinitrile in aldehyde trinitrile and B.) spectral evidence
of aldehyde formation [1H NMR (500 MHz, DMSO-d6); 13C NMR (125 MHz, DMSO-d6)]
The aldehyde trinitrile (5-4) was treated with sodium borohydride subsequently and
alkoxide intermediate was quenched with HCl to afford the alcohol trinitrile (5-5) shown in
Figure 5.5.
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Figure 5.5. Synthesis for converting aldehyde trinitrile into alcohol trinitrile
Prior to reduction, the primary alcohol handle of the alcohol trinitrile (5-5) tripodal
structures was protected via a 48-hour reflux with TBS triflate to yield the TBS protected alcohol
trinitrile (5-6) shown in Figure 5.6.

Figure 5.6. Synthesis of the TBS protected alcohol trinitrile tripod via TBS-OTf reflux of the
alcohol trinitrile
This TBS protected alcohol trinitrile (5-6) can then be reduced via a combination of
excess sodium borohydride, Raney nickel, and 8M sodium hydroxide to form the TBS protected
alcohol triamine (5-7) (shown in Figure 5.7) for linking to chelating pendants.

Figure 5.7. Synthesis of the TBS alcohol triamine tripod via Raney Ni/NaBH4 reduction
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General conclusions

Synthesis of the TBS protected alcohol triamine has been completed to this point and is ready for
coupling to the 7-carboxy-8-hydroxyquinoline chelating pendants. The biggest hurdle in this
synthesis was getting the nitrile groups to reduce into primary amines successfully-the Raney Ni,
NaBH4, and NaOH conditions finally broke through this barrier after many attempts with other
reducing conditions. Also, another big improvement was switching the imine trinitrile synthesis
from a reflux in DMF approach to a pressure reactor in toluene approach, which allowed for
yields of 50% and large-scale reactions moving forward for easier transformations.
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Chapter 6

Experimental

General Experimental

INSTRUMENTATION
1H

NMR
All intermediates and final products were characterized by NMR. 1H NMR and 13C

NMR were acquired with a Varian Mercury 400 BB NMR, a Bruker 500 BB NMR, and/or a
Bruker 700 NMR. Chemical shifts are reported in parts per million (ppm) relative to
tetramethylsilane (TMS) unless otherwise noted. Chloroform-d, dimethylsulfoxide-d6, methanold4, and tetrahydrofuran-d8 were purchased from Cambridge Isotope Labs and were stored over
molecular sieves (4Å).

GCMS
Shimazdu GCMS-QP2010 equipped with a 30.0 m SHRX1-5MS column (thickness: 0.25
μm, diameter: 0.25 μm) and 70 eV electron impact detector. The injector temperature (splitless
injection) was held at 250 °C and the detector at 260°C. The column temperature increased from
45°C to 250°C at 15°C /min and held at 250°C for 0 min, after a solvent delay of 5.5 min. Flow
rate was 1 mL/min and total run time was 14.67 minutes.

SOLVENTS AND REAGENTS
All solvents and reagents were purchased from Fisher, Alfa Aesar, Sigma Aldrich,
Pharmco Aaper, and Acros. All chemicals were used as is and required no further purification.
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CHROMATOGRAPHY
Reaction products were purified by flash column chromatography using Silicycle Inc.
silica gel (60 Å, 230–400 mesh). Thin layer chromatography was performed on Agela
Technologies TLC Silica plates (silica gel 60 GF254) and visualization was accomplished with
UV light.

ENZYMATIC INCUBATIONS
NADPH and magnesium dichloride were purchased from Sigma Aldrich. Potassium
phosphate buffer (0.5 M), pooled human liver microsomes, and cytochrome P450 isoforms 1A2,
3A4, and 2E1 were purchased from Corning Life Sciences in Woburn, MA. MilliQ water was
used in all incubations, which were carried out in a 37°C water bath.
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DETAILED EXPERIMENTAL

Synthesis of 1,4-dihydronaphthalene (1-2) via Birch Reduction:
A Dewan condenser apparatus was constructed filled with solid CO2 and acetone bath to
condense liquid ammonia (NH3). Glassware was extensively dried to prevent against potential
fire hazards. A three-neck flask was filled with naphthalene (5.0175g) and dry diethyl ether
(Et2O) (80mL); and the flask was fitted with two rubber septa, magnetic stir bar, nitrogen
atmosphere, and Dewan condenser. Sodium metal (Na°) (1.62g) was added to the 3-neck flask in
fine chunks after being rinsed in hexanes to remove trace mineral oil, which Na° is stored in. The
flask was hastily sealed to maintain dryness and safety. The solution changed from clear to blue
to green back to deep blue. The reaction was stirred for 20 minutes. Some brown precipitate
formed during the reaction indicative of iron contamination from rust in the NH3 gas cylinder.
The reaction was quenched by adding NH4Cl (15mL) dropwise. After the first 7mL the
solution turned blue back to green and turned a tinged green at 8mL total. Solution was blue
again after 9mL total of mild acid and the solution was completely clear after all 15mL was
added.
Clear solution was transferred to a round bottom flask and condenser by vacuum and
reduced pressure for 60 minutes to remove liquid NH3 to yield white solid with brown iron
precipitate contaminate.
Solution was extracted with Et2O (2 x 30mL) to yield a brown aqueous layer containing
inorganic iron precipitate salt and a clear organic layer containing crude product. Organic layer
was dried with anhydrous Na2SO4 and was condensed to a bright white solid (3.25g crude, 49%

51

yield), which was determined to be a 2:1 mixture of 1,4-dihydronapthalene (1-2) and
naphthalene (1-1).
1,4-dihydronapthalene (1-2) as a crude white solid mixture: 1H NMR (400 MHz, CDCl3)
δ 7.10 (m, 4H), 5.91 (t, 2H), 3.40 (d, 4H).

Synthesis of epoxide (1-3) using mCPBA:
1,4-dihydronapthalene (1.625g) was dissolved in dichloromethane (DCM) (30mL) in 250mL 3neck flask fitted with a nitrogen inlet and magnetic stir bar. The flask was placed in an ice bath at
0°C. The solution turned pale yellow. To this solution, mCPBA (2.76g) dissolved in another
portion of DCM (30mL) was added dropwise via a dropper funnel. Residual mCPBA in the
dropper funnel was rinsed into the reaction solution. A thick white and yellow precipitate formed
in the flask. KI paper was used to see if the oxidizing agent (mCPBA) was working. The reaction
was allowed to stir for 18 hours total before filtering off the precipitate. The filtrate was washed
with NaHSO3 (2 x 25mL), NaHCO3 (2 x 50mL) and brine (NaCl) (2 x 25mL) before being
condensed via vacuum into crude epoxide (1-3) and 1,4-dihydronapthalene (1-2) mixture (2.24g)
as a yellow/orange solid. TLC analysis (3:1 hexanes:diethyl ether solvent system) indicated that
the epoxide required further purification.
Crude epoxide was purified via silica column to yield pure epoxide (1.03g, 63.9%).
Epoxide (1-3) as a yellow-white solid: 1H NMR (400 MHz, CDCl3) δ 7.14 (m, 2H), 7.04 (m,
2H), 3.48 (m, 2H), 3.31 (d, J=16.16Hz, 2H), 3.17 (d, J=13.84Hz, 2H).
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Synthesis of brominated epoxide (1-4) via photochemical NBS bromination:
AIBN radical initiator was dissolved in carbon tetrachloride (CCl4) (10mL) and left in hood
overnight. Epoxide (0.160g, 1eq.) was combined with NBS (0.234g, 1.1eq.) in a 3-neck flask
fitted with a nitrogen inlet, magnetic stir bar and reflux condenser. AIBN solution was added to
the flask. Then, CCl4 (30mL) was added to completely dissolve all solids for a total amount of
40mL of CCl4. Once all of the solids were dissolved via stirring, an intense visible light source
was shined onto the 3-neck flask and solution. The light source heated the solution while
activating the AIBN to a reflux. Reaction was run for 8 hours and at reflux after 1 hour due to
immense heat from the light source. TLC analysis (3:1 hexanes:diethyl ether solvent system)
indicated that the brominated epoxide formed after the first hour and in concentrated amounts
after the full 8 hours.
Crude brominated epoxide was purified via column to yield pure brominated epoxide
(0.160g, theoretical yield 0.250g, 64.0% yield). Brominated epoxide (1-4) as a yellow oil: 1H
NMR (400 MHz, CDCl3) δ 8.08 (dd, 1H), 7.68 (dt, 1H), 7.53 (dt, 1H), 7.25 (dd, 1H), 5.54 (d,
1H), 3.78 (t, 1H), 3.65 (t, 1H), 3.29 (d, 2H).

Synthesis of 4,5-benzoxepin (1-5) via dehydrohalogenation of brominated epoxide:
Potassium t-butoxide (0.224g, 4 eq.) was dissolved in dry THF (20mL) in a 3-neck flask fitted
with a nitrogen inlet, magnetic stir bar and dropper funnel. The 3-neck flask was placed in an ice
bath. Solution was allowed to stir to ensure better solubility of potassium t-butoxide. Brominated
epoxide (0.114g, 1eq.) dissolved in dry THF (5mL) was added drop wise in portions to the
solution every 10 minutes for 50 minutes total. After the 50 minutes was up, dry THF (1mL) was
added to the dropper funnel to rinse residual brominated epoxide starting material into the
solution and then the dropper funnel was replaced with a calcium chloride drying column.
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Reaction was stirred for 24 hours and ice was allowed to melt after the first 8 hours. Using TLC
analysis (3:1 hexanes:diethyl ether solvent system), it was determined that 4,5-benzoxepin
formed after 1 hour in trace amounts and in concentrated amounts after 20 hours.1,3,5
Crude 4,5-benzoxepin was purified via column to yield pure 4,5-benzoxepin (0.060g,
theoretical yield 0.072g, 83.3% yield). 4,5-benzoxepin (1-5) as a yellow powder solid: 1H NMR
(400 MHz, CDCl3) δ 6.90 (m, 2H), 6.63 (m, 2H), 5.64 (d, J=7.52Hz, 2H), 5.01 (d, J=8.20Hz,
2H).

Two electron oxidation of 4,5-benzoxepin (1-5) using cerium (IV) ammonium nitrate (CAN):
4,5-benzoxepin (0.060g) was combined with CAN (0.457g) in a scintillation vial fitted with a
small magnetic stir bar and were dissolved in acetone (5mL). The vial was wrapped in foil so
that the reaction could be stirred in the dark. After one hour diethyl ether (2mL) was added to
fully dissolve products. The reaction stirred for 48 hours to yield crude “fraction 1” unidentified
product (0.100g crude yield). The reaction was placed in a freezer to avoid decomposition of
products and was purified via 3:1 hexanes:diethyl ether silica flash column under N2 after 1
week. 1H NMR indicates the presence of “fraction 1” when compared to a standard 1H NMR of
“fraction 1” 1-7 (0.057g, 43.0% yield). 1H NMR (500 MHz, CDCl3) δ 8.01 (dd, 2H), 7.61 (dt,
2H), 7.40 (dt, 2H), 7.34 (d, 2H), 6.67 (s, 2H), 6.48 (d, 2H), 5.94 (d, 2H).

Enzymatic reactions using enzymes pHLM and 2E1 with benzene substrate:
Benzene (64mM) underwent enzymatic reactions in 4 trials with either cytochrome P450
isoforms 2E1 (50pmol/mL or 5.0pmol/mL for trials 1 and 2) or pHLM (12.5μL or 1.25μL for
trials 3 and 4). Each was combined buffer (100μL), NADP+ solution A (25μL), NADPH solution
B (5μL), and milli-Q water (355.16μL). Enzymes were pre-incubated for 5 minutes prior to
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addition to the solution. Solution was heating in a water bath at a constant 37°C for 30 minutes.
Each trial was extracted with dichloromethane (3 x 600μL) and the organic layer was kept each
time. Organic layers were stored at -80°C before analysis.
GCMS analysis was performed on the final products to see if muconic acid or phenol
formed as products as a control experiment and neither product was seen. 1H NMR could not be
performed due to the scale of the reaction.48

Enzymatic reactions using enzymes pHLM and 1A2 with 4,5-benzoxepin (1-5) substrate:
Enzymatic reactions with 4,5-benzoxepin (1-5) were explored using different concentrations of
substrate (4,5-benzoxepin) and using a standard addition method using “fraction 1” standard as
the expected product. The concentrations of 4,5-benzoxepin that were tested were 50μM,
100μM, 150μM and 200μM with cytochrome P450 isoform 1A2 (25pmol/mL, 25μL) for trials 14, respectively and were repeated for trials 5-8 with isoform pHLM (0.25mg/mL, 12.5μL). All 8
trials had the same amounts of buffer (200μL), NADP+ solution A (50μL) and NADPH solution
B (10μL) combined with substrate, enzyme, and milli-Q water. Milli-Q water was added to dilute
to the proper concentrations with the amounts for a total 1mL reaction volume. Enzymes were
pre-incubated for 5 minutes prior to addition to the solution. Solution was heating in a water bath
at a constant 37°C for 30 minutes. Each trial was extracted with dichloromethane (3 x 600μL)
and the organic layer was kept each time. Standard “fraction 1” (143mM, 2.4μL) was added half
of each trial in a separate container for 16 total samples. Organic layers were stored at -80°C
before analysis.
GCMS analysis was performed on the final products to see if “fraction 1” formed as
products as a control experiment and analysis indicated that “fraction 1” formed and unreacted
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4,5-benzoxepin remained for substrate concentrations of 150μM and 200μM whereas the 50μM
and 100μM could not be determined because their respective peaks are buried in the baseline.

Enzymatic reactions using enzyme P450 1A2 with naphthalene substrate and revised
regenerating system:
Revisions were made to the NADPH regenerating system to include excess MgCl2 as a divalent
cation to balance negative charges on the phosphate groups of ATP and this allowed for mass
spectrometry analysis of the metabolism of naphthalene to naphthol, which is the known
metabolite of naphthalene and the product was compared to a pure standard of naphthol with a
yield in excess of 50%.

Enzymatic reactions using enzymes P450 1A2 and P450 3A4 with 4,5-benzoxepin substrate and
revised regenerating system:
The new regenerating system employed in the naphthalene to naphthol control experiment was
used in the same reaction as all other enzymes reactions with 4,5-benzoxepin as a substrate again
to yield carboxaldehyde 1-6 and “Fraction 1” as products in a 2:1 ratio (product 1-6 : “Fraction
1” product 1-7) when compared to standards of the two compounds. Standard additions were not
done in this procedure.

Attempted synthesis of dimer (1-15) and resulting synthesis of benzoisocoumarin (1-16) via
nickel homocoupling:
A test tube was fitted with a small magnetic stir bar and monomer 6-bromo-dibenz[b,d]oxepin7(6H)-one (0.050 g, 1 eq.), anhydrous NiCl2 (0.0224 g, 1 eq.), Zn dust (0.0113 g, 1 eq.), and

56

2,2’-bipyridine (0.0540g, 2 eq.) were added. Dry pyridine (0.0139 mL, 1 eq.) and dry CHCl3 (15
mL) were added via pipette to the test tube. The test tube was fitted with a septum and sealed
with parafilm. The test tube was then purged for 5 minutes with argon and then sealed with an
argon atmosphere. Solution was stirred overnight and the headspace was analyzed via GC and
was identified with a methane standard to be generating methane. Solution was gravity filtered
into a separatory funnel and was washed with 1M HCl (3 x 25 mL) and the organic layer was
dried with sodium sulfate. The organic layer/CHCl3 was evaporated via rotary evaporator and
high vacuum to yield an orange solid mixture of benzoisocoumarin (1-16) and
dibenz[b,d]oxepin-7(6H)-one (1-13) (0.0352g) with no starting material remaining. A crude
NMR was obtained for the product (in Appendix). Products were not separated because it
demonstrated repeatability of group member Dr. Guevara’s work.

Synthesis of 2-allyl-1-allyloxybenzene (2-9) via o-allylation:
Building block starting material 2-allylphenol (2-8) (1.500g, 1.458mL, 1.0eq) was combined
with allyl bromide (1.158mL, 1.2eq) and K2CO3 (1.854g, 1.2eq) and dissolved in acetonitrile
(35.0mL) in a 250mL round bottom flask. Solution was refluxed under a nitrogen atmosphere for
4 hours. Acetonitrile was evaporated and the liquid and white solid were redissolved in Et2O
(25mL) for washes. The organic layer was washed with brine (3 x 25mL), water (3 x 25mL), and
sodium bicarbonate (10% w/v) (3 x 25mL). A crude NMR was run and it was determined that all
of the 2-allylphenol (2-8) was converted to the product 2-9 based on literature chemical shift
values. A silica flash column was run using a 15:1 hexanes:ethyl acetate solvent system to yield
pure product 2-9.
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Crude 2-allyl-1-allyloxybenzene was purified via column to yield pure 2-allyl-1allyloxybenzene (0.743g, theoretical yield 1.948g, 38.1% yield). 2-allyl-1-allyloxybenzene (2-9)
as a yellow liquid: 1H NMR (400 MHz, CDCl3) δ 7.16 (m, 2H), 6.89 (dt, 1H), 6.82 (d, 1H), 6.03
(m, 2H), 5.41 (dq, 1H), 5.24 (dq, 1H), 5.05 (m, 2H), 4.53 (dt, 2H), 3.41 (d, 2H).

Synthesis of 2,5-dihydro-1-benzoxepin (2-10) via ring closing metathesis:
2-allyl-1-allyloxybenzene (2-9) (0.618g) was dissolved in dry dichloromethane (20mL) and
combined with Grubbs first generation catalyst (0.161g, 0.05eq). The solution was purged
continuously with nitrogen to ensure that the catalyst had little to no atmospheric moisture
exposure. The solution was attached to a reflux condenser fitted with a nitrogen inlet and was
refluxed for 2 hours. A crude NMR sample was made via an alumina plug and according to
relative NMR integrations a 95% conversion of starting material 2-9 was converted to product 210. A silica flash column was run using a 10:1 hexanes:ethyl acetate solvent system to yield pure
product 2-10.
Crude 2,5-dihydro-1-benzoxepin (2-10) was purified via column to yield pure 2,5dihydro-1-benzoxepin (0.500g, theoretical yield 0.517g, 96.7% yield). 2,5-dihydro-1-benzoxepin
(2-10) as a yellow solid: 1H NMR (400 MHz, CDCl3) δ 7.19 (m, 1H), 7.09 (d, 1H), 7.03 (m,
2H), 5.85 (dt, 1H), 5.49 (dt, 1H), 4.59 (t, 2H), 3.49 (t, 2H).

Attempted synthesis of 2,5-dibromo-1-benzoxepin (2-11) via Br2 bromination of an alkene:
Bromine (Br2) (0.150mL, 0.81eq) was dissolved in a 1:1 solution of chloroform:dichloromethane
(15mL) in a vial. 2-10 (0.500g, 1.0eq) was dissolved in the same chloroform:dichloromethane
solution (30mL) in a separate 250mL round bottom flask. The bromine solution was pipetted into
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the round bottom was flask and the solution was stirred at -78°C for 30 minutes in a dry ice and
acetone bath. Solution was filtered through three pipet columns filled with silica to filter off
excess bromine solution. Attempted recrystallization with hexanes (8mL) was unsuccessful. GCMS data and a very impure crude NMR have been obtained for crude 2-11 to this point.

Synthesis of 1,4-dihydro-1,4-epoxynaphthalene (1-9) via Diels Alder with benzyne:
Furan (9.4 g, 10 mL) was dissolved in 1,2-dimethoxyethane (10 mL) in a 100 mL round bottom
flask. This was then set to reflux. In two separate Erlenmeyer flasks, a solution of isoamyl nitrite
(4 mL) in DME (10 mL), and a solution of anthranilic acid (1-8) (2.74 g) in DME (10 mL). Each
solution was then added in 2 mL portions every 9 minutes. Once additions were complete, the
solution was then set to reflux for a further 30 minutes. The reaction was then quenched with
sodium hydroxide (0.5 g) in water (25mL). The product was then extracted using light petroleum
(3 x 15 mL), washed with water (6 x 15 mL), and dried using magnesium sulfate.
Pure 1,4-dihydro-1,4-epoxynaphthalene (1-9) (2.51 g, theoretical yield 2.95 g, 85% yield)
was collected as a red/orange solid: 1H NMR (400 MHz, CDCl3) δ 7.25 (m, 2H), 7.03 (t, 2H),
6.97 (m, 2H), 5.71 (m, 2H).

Synthesis of 4,5-benzoxepin (1-5) using photoreaction:
1,4-dihydro-1,4-epoxynaphthalene (6.04 g) was dissolved in absolute ethanol (400 mL) in a 500
mL round bottom flask to prepare stock solution. The solution was set to stir while purging with
N2. From the stock solution, 1,4-dihydro-1,4-epoxynaphthalene (1-9) was added to two separate
phototubes. The phototubes were then fitted with stoppers and again purged with N2. The
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solutions were then subjected to 254 nm light for 24 hours. After the light exposure, the solvent
was evaporated and crude 4,5-benzoxepin was collected as a brown/red oil.
Crude 4,5-benzoxepin was purified using a hexanes column and pure 4,5-benzoxepin (15) (0.13 g, theoretical yield 0.751 g, 17.3% yield) was collected as a yellow solid: 1H NMR (400
MHz, CDCl3) δ 6.90 (m, 2H), 6.63 (m, 2H), 5.64 (d, J=7.52Hz, 2H), 5.01 (d, J=8.20Hz, 2H).

Two-electron oxidation of 4,5-benzoxepin using cerium (IV) ammonium nitrate (CAN):
CAN (1.99 g, 2 eq) was dissolved in acetone (50 mL) in a 250 mL 3-neck flask fitted with a
dropper funnel and 2 stoppers. 4,5-benzoxepin (0.262 g, 1 eq) was dissolved in acetone (50 mL)
and added to the dropper funnel. The system was set into the dry ice bath (-78oC), purged with
N2, and aluminum foil was used to minimize light exposure. The 4,5-benzoxepin solution was
added in 5 mL portions every 2 minutes until all reagent was used. The dropper funnel was then
washed with acetone (5 mL) and added to the reaction. The reaction was then set to stir for 1
hour. Excess CAN reagent was gravity filtered and product was condensed via evaporation.
Product was assumed to be “fraction 1” (1-7) from previous group reactions, but after NMR
analysis it seemed to be purely “fraction 2” (1-10).
Crude product was purified via a 3:1 hexanes: ether column and pure “fraction 2” (1-10)
was collected and evaporated to a yellow solid: 1H NMR (400 MHz, CDCl3) δ 7.54 (d, 2H), 7.46
(dt, 2H), 7.39 (d, 2H), 7.29 (dt, 2H), 7.01 (d, 2H), 6.36 (d, 2H), 6.25 (d, 2H), 5.79 (d, 2H).
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Synthesis of 5-bromo-2-dihydro-1-benzoxepin (2-12a) and 2-bromo-5-dihydro-1-benzoxepin (212b) via photochemical NBS bromination:
2,5-dihydro-1-benzoxepin (2-10) (2.07 g, 1.0 eq) was dissolved in carbon tetrachloride (25 mL)
and combined with N-bromosuccinimide (3.034 g, 1.2 eq) in a 250mL round bottom flask.
Separately, azobisisobutyronitrile (AIBN) (0.351g, 0.15eq) was dissolved in carbon tetrachloride
(10 mL) and then added to the reaction flask. The solution was subjected to a visible light/ heat
lamp while refluxing under a nitrogen atmosphere for eight hours. Carbon tetrachloride was
evaporated, and the solution was re-dissolved in dichloromethane (35 mL) for washes. The
organic layer was washed with sodium bicarbonate (10% w/v) (3 x 25 mL), brine (3 x 25 mL),
and water (4 x 25 mL). A silica flash column was run using a 3:1 hexanes: diethyl ether solvent
system. NMR data confirmed that there was a bromination at both the allylic position as well as
the benzylic position, affording a dibrominated compound (2-12c) making this synthetic route to
2,3-benzoxepin very difficult to continue.

Synthesis of 2,3-benzoxepin (2-7) via Diels Alder reaction with pyridazine N-oxide:
Pyridazine N-oxide (2-13) (0.518 g) was dissolved in DME (10 mL) in a 100 mL 3-neck flask
and fitted with a condenser. Separate solutions of anthranilic acid (1-8) (0.712 g) and isoamyl
nitrite (1.1 mL) were each individually dissolved in DME (10 mL) and placed into dropper
funnels. While refluxing each solution was dropped into the 3-neck flask with portions (3mL)
every 10 minutes. Once each reagent was completely used, the dropper funnels were each
washed with DME (5mL) and drained into the reaction flask. The reaction was then refluxed for
a further 45 minutes. The reaction was quenched with sodium hydroxide (0.555 g) in water
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(25mL). The product was then extracted using petroleum ether (3 x 25 mL), followed by washes
with brine (3 x 20 mL) and water (3 x 25 mL), and finally dried using sodium sulfate. This was
followed by several hours on a high vacuum to remove excess benzene.
Pure 2,3-benzoxepin (2-7) (0.222 g, theoretical yield 0.865 g, 25.67% yield) was
collected as an orange red solid: 1H NMR (400 MHz, CDCl3) δ 7.31 (t, 1H), 7.28 (d, 1H), 7.09 (t,
1H), 6.95 (d, 1H), 6.69 (d, 1H), 6.25 (d, 1H), 6.06 (dd, 1H), 5.49 (t, 1H).

Two electron oxidation of 2,3-benzoxepin using cerium (IV) ammonium nitrate (CAN):
CAN (0.304 g, 2.0 eq) was dissolved in acetone (20 mL) in a 100 mL 3-neck flask fitted with a
dropper funnel and 2 stoppers. 2,3-benzoxepin (0.040 g, 1.0 eq) was dissolved in acetone (15
mL) and added to the dropper funnel. The system was set into the dry ice bath (-78oC), purged
with N2, and aluminum foil was used to minimize light exposure. The 2,3-benzoxepin solution
was added in portions (5mL) every 2 minutes until all reagent was used. The dropper funnel was
then washed with acetone (5mL) and added to the reaction. The reaction was then set to stir for
20 hours. After evaporation of solvent, a brown product had been collected.
To this point only a crude NMR (in Appendix) has been run, and further analysis is
necessary to determine the product of this reaction.

Epoxidation of 2,3-benzoxepin using mCPBA:
2,3-benzoxepin (0.053 g, 1.0 eq) was dissolved in DCM (15 mL) in a 100 mL round bottom flask
sitting in an ice bath. mCPBA (0.077 g, 1.2 eq) was measured in a scintillation vial and dissolved
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in DCM (5 mL). While the solution was stirring, the mCPBA solution was pipetted into the
reaction flask. The reaction was then set to stir for 22 hours. The crude mixture was then gravity
filtered into a separatory funnel. With DCM as the organic layer the product was washed with
sodium bisulfate (2 x 25 mL), sodium bicarbonate (2 x 50 mL), and finally brine (2 x 25 mL).
DCM was then evaporated, and product turned from a yellow solution to an orange solid.
Crude orange solid was purified via 3:1 hexanes:ethyl acetate column and methanol flush
to yield more polar product as a yellow pure solid (0.010g, 16.98% yield). 1H NMR (500 MHz,
CDCl3) δ 7.37 (m, 1H), 7.29 (d, 1H), 7.15 (m, 1H), 6.85 (t, 1H), 6.40 (s, 1H), 6.03 (d, 1H), 5.08
(d, 1H), 4.66 (s, 1H).

Enzymatic reactions using cytochrome P450 isoform 1A2 on 4,5-benzoxepin and 2,3-benzoxepin
substrates.:
Enzymatic studies were performed on both substrates, the 2,3-benzoxepin being a new substrate
and the 4,5-benzoxepin for comparative studies to previous enzyme reactions. Three sets of each
substrate were tested. A 0.5 M buffer (100 μL), 33.65 mM NADP+ (3.72 μL), 88.62 mM
glucose-6-phosphate (14.11 μL), 44.2 μM/mL G6P-DH (22.62 μL), 98.4 mM magnesium
dichloride (17.77 μL), 1000 pmol/mL isoform 1A2 (25 μL), water (314.78 μL), and either 4,5benzoxepin (200mM, 3 μL) or 2,3-benzoxepin (200mM, 3 μL) were sequentially added into
Eppendorf tubes. The solutions were then placed into a bead bath at a constant 37oC for 30
minutes. The solutions were then all quenched with acetonitrile (250 μL) and centrifuged for 5
minutes at 13500 rpm. The products were then extracted using DCM (501 μL) as the organic
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layer which was collected again centrifuged for 2 minutes at 13500 rpm. The organic extracts
were then stored for GCMS analysis at -17oC.

Synthesis of 2,2-dimethyl-1,3-dioxolan-4-one/glycolic acid acetonide (3-3):
A suspension of phosphorus pentoxide (20g) in Et2O (50mL) in a 3-neck flask was cooled to 5oC in a NaCl/ice water bath. Attached to the 3-neck flask was an addition funnel containing
glycolic acid (5g) dissolved in acetone (25mL). When P2O5 clumped, it was kneaded with a
spatula. The solution was decanted into a round bottom flask and evaporated via rotovap into an
amber oil of 2,2-dimethyl-1,3-dioxolan-4-one (3-3) (1.448g, 18.7% yield). 1H NMR (400 MHz,
CDCl3) δ 4.32 (s, 2H), 1.56 (s, 6H).

Synthesis of N-glycolyldiethanolamine (3-5):
Combined 2,2-dimethyl-1,3-dioxolan-4-one (1.448g) with diethanolamine (1.312g) and dry
DCM (45mL) in a round bottom flask. Solution was stirred at room temperature for 8 hours and
evaporated to crude N-glycolyldiethanolamine (1.667g crude). Crude product was dissolved in
DCM (5mL) and ran through a silica flash column (4:1 methanol:ethyl acetate) to obtain pure Nglycolyldiethanolamine (3-5) (1.414g, 69.5% yield) after evaporation of solvent via reduced
pressure. 1H NMR (400 MHz, DMSO-d6) δ 4.85 (br. s, 1H), 4.76 (br. s, 1H), 4.35 (br. s, 1H),
4.12 (s, 2H), 3.50 (m, 4H), 3.36 (t, 2H), 3.27 (t, 2H).
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Attempted synthesis of 1-methyl-4-silatranone (3-9):
N-glycolyldiethanolamine (0.100g) was combined with triethoxymethylsilane (0.109g, 0.122mL)
and dissolved in tetrahydrofuran-d8 (2.1mL, 3 ampules) in a 50 mL round bottom flask fitted
with a reflux condenser, magnetic stir bar, and N2 inlet. Solution was stirred at room temperature
for 72 hours followed by heating at 40°C for 72 hours, and finally was refluxed (66°C) for 1
addition week. Crude reaction solution was immediately analyzed for NMR and produced no
reaction.

Attempted synthesis of 1-methyl-4-silatranone (3-9):
Triethoxymethylsilane (0.109g, 0.122mL) was combined with N-glycolyldiethanolamine
(0.100g, 1eq.) neat in a 100mL round bottom flask and attached to a rotary evaporator. Crude
white solid resulted from reduced pressure and was dissolved in a 1:1 mix of CDCl3 and CD3OD
for NMR analysis. 1H NMR (400 MHz, CDCl3, CD3OD) δ 4.31 (s, 2H), 3.90 (m, 4H), 3.71 (m,
9H), 3.25 (m, 4H), 3.00 (m, 9H), -0.15 (s, 2H).

Attempted synthesis of 1-propyl-4-silatranone (3-7):
1,1-dichlorosilacyclobutane (0.0865g, 0.0727mL) was combined with N-glycolyldiethanolamine
(0.100g, 1eq.) neat in a 100mL round bottom flask and attached to a rotary evaporator. Fuming
of HCl byproduct was observed. Crude white solid resulted from reduced pressure and was
dissolved in a 1:1 mix of CDCl3 and CD3OD for NMR analysis. Only crude NMR was run for
this sample as it contained a lot of oligomeric material and was difficult to characterize/purify.
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Synthesis of 2-Hydroxy-N,N-Bis(2-hydroxyethyl)acetamide/N-glycolyldiethanolamine (3-5)79:
This compound was synthesized according to the procedure of Daryaee et al79 with an improved
procedure80 for synthesis of the acetonide starting material. Glycolic acid acetonide (0.145 g)
was dissolved in dichloromethane (DCM) (5 mL) with dissolved diethanolamine (0.2 g) and
reacted for 1 hour at room temperature. The product 3-5 was a clear yellow oil that was purified
using column chromatography (silica gel, methanol: ethyl acetate, 4:3). 1H NMR (400 MHz,
CDCl3) δ 3.32-3.34 (2H, XX’ of AA’XX’), 3.60-3.62 (2H, XX’ of AA’XX’), 3.77-3.80 (2H,
AA’ of AA’XX’), 3.93-3.96 (2H, AA’ of AA’XX’), 4.27 (2H, s). 13C NMR (100 MHz, CDCl3) δ
31.15, 42.79, 50.57, 60.36, 61.15, 200.04. IR (neat): 3246, 2872, 1590, 1063, 844 cm-1. IR
(CH3CN): 3623, 1631, 1037, 832 cm-1.
Synthesis of N,N-Bis(2-hydroxyethyl)acetamide (4-1)76:
Diethanolamine (12.1 g, 115 mmol) was added to a round bottom flask followed by acetic
anhydride (11.2 mL, 115 mmol) and THF (10 mL). The mixture was refluxed for 1 hour, then
cooled to room temperature and concentrated. A small portion of the mixture was dissolved in
CDCl3 then treated with a few powdered granules of KOH and stirred for 10 minutes to
neutralize acetic acid. Sodium sulfate was added and the mixture filtered through a glass wool
plug to afford pure 4-1 (39% yield). 1H NMR (400 MHz, CDCl3) δ 2.16 (3H, s), 3.48-3.50 (2H,
XX’ of AA’XX’), 3.52-3.54 (2H, XX’ of AA’XX’), 3.77-3.79 (2H, AA’ of AA’XX’), 3.80-3.82
(2H, AA’ of AA’XX’). 13C NMR (100 MHz, CDCl3) δ 22.29, 50.62, 53.39, 60.77, 61.41,
173.31. IR (neat): 3347, 2934, 1606, 1037 cm-1. IR (CH3CN): 3092, 1639, 1037 cm-1.
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Synthesis of N,N-Diethyl-2-hydroxyacetamide (4-3)80:
This compound had been prepared earlier and characterized by Andreas et al.15 N,N-Diethyl-2bromoacetamide (0.182 mL, 1.3 mmol) was added to a round bottom flask with a magnetic stir
bar. 1 M NaOH (10 mL) was added to the flask and stirred at room temperature for 30 hours.
The mixture was extracted with ethyl acetate (3 x 25 mL). The combined organic layers were
washed with water and brine, dried, and concentrated under reduced pressure to afford 4-3 (51
mg, 31% yield). 1H NMR (400 MHz, CDCl3) δ 1.16 (3H, t, J=7.2 Hz), 1.19 (3H, t, J=7.2 Hz),
3.17 (2H, q, J=7.2 Hz), 3.45 (2H, q, J = 7.2 Hz), 4.15 (2H, s). 13C NMR (100 MHz, CDCl3) δ
13.08, 14.05, 40.17, 40.66, 59.87, 170.77. IR (neat): 3407, 2975, 1633, 1076 cm-1. IR (CH3CN):
3092, 1647, 1081, 1037 cm-1.
Synthesis of N,N-Bis[2-(acetyloxy)ethyl]acetamide (4-4)76:
Diethanolamine (11.13 g, 95 mmol), was placed in a round bottom flask with THF (25 mL) and a
magnetic stir bar. The flask was cooled to 0oC and acetic anhydride (10.3 mL, 98 mmol) was
added dropwise by pipet. The mixture was then refluxed at 90oC for 1 hour and 15 minutes. The
reaction was stirred for another 4 hours at room temperature, then concentrated under reduced
pressure. The resulting oil was dissolved in ethyl acetate and washed with 1M HCl, 1M NaOH,
and brine, dried and concentrated to give 4-4 (4% yield). 1H NMR (400 MHz, CDCl3) δ 2.06
(3H, s), 2.08 (3H, s), 2.15 (3H, s), 3.60-3.65 (4H, XX’ of AA’XX’), 4.20-4.23 (4H, AA’ of
AA’XX’). 13C NMR (100 MHz, CDCl3) δ 20.58, 20.69, 21.30, 45.15, 48.06, 61.60, 62.04,
170.47, 170.63, 171.02. IR (neat): 2959, 1734, 1638, 1234, 1034 cm-1. IR (CH3CN): 1739, 1643,
1234, 1037 cm-1.

67

Synthesis of imine trinitrile (5-3):
Combined acetaldehyde (17mL), toluene (30mL), K2CO3 (2.5g), and Na2SO4 into a 250mL
Schlenk flask. Fitted Schlenk flask with a septum and purged with N2 atmosphere. The flask was
placed in an ice bath and cyclohexylamine (40mL) was syringe loaded into the flask slowly.
Once additions were completed, solution was allowed to stir for 30 minutes. Syringed amber
liquid/ top organic layer into a glass pressure reactor with acrylonitrile (50mL). Sealed pressure
reactor with a greased cap and heated glass pressure reactor in an oil bath behind a blast shield
for 4 hours at 170°C. Solution turned dark black. Reaction was depressurized and cooled to 0°C
slowly and Et2O (100mL) was used to precipitate into a yellow crude solid and was vacuum
filtered into crude imine trinitrile (22.4g, 51% yield). 1H NMR (500 MHz, CDCl3) δ 7.43 (s, 1H),
3.08 (m, 1 H), 2.34 (t, J=7.94Hz, 6H), 1.93 (t, J=7.94Hz, 6H), 1.78-1.30 (m, 10H). 13C NMR
(125 MHz, CDCl3) δ 160.30, 119.09, 68.36, 45.78, 36.05, 30.77, 25.44, 24.33, 11.88.

Synthesis of aldehyde trinitrile (5-4):
Imine trinitrile (22.4g) was placed into a 250mL round bottom flask and was combined with H2O
(130mL) and concentrated HCl (5mL). Solid does not dissolve leaving a suspension. A reflux
condenser and N2 inlet were attached to the flask and was refluxed for 30 minutes. Cooled
solution slightly and hot vacuum filter off black impurities. Placed the filtrate in an ice bath to
precipitate aldehyde as a yellow solid. Vacuum filtered to isolate solid product as a yellow
powder (9.8g, 95% yield). 1H NMR (500 MHz, DMSO-d6) δ 9.44 (s, 1H), 2.44 (t, J=8.09Hz,
6H), 1.86 (t, J=8.09Hz, 6H). 13C NMR (125 MHz, DMSO-d6) δ 203.31, 122.86, 52.06, 28.48,
14.23.
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Synthesis of alcohol trinitrile (5-5):
Aldehyde (9.8g) was dissolved in methanol (50mL) in a 250mL round bottom flask with a
magnetic stir bar in an ice bath. NaBH4 (1.82g, 1eq.) was added to the solution and was allowed
to stir overnight at 0°C to room temperature. Solution becomes homogeneous as it reacts.
Quenched reaction with H2O (50mL). 3M HCl was added to the solution until pH=1. Methanol
was rotovapped off to yield product floating on remaining H2O. The aqueous solution was
extracted with dichloromethane (3 x 75mL) and organic extracts were dried with Na2SO4.
Dichloromethane was evaporated via rotovap and high vacuum to yield alcohol trinitrile as an
orange oil (9.7g, 99% yield). 1H NMR (500 MHz, CDCl3) δ 3.55 (s, 2H), 2.42 (t, J=7.94Hz, 6H),
1.87 (br. s, 1H), 1.77 (t, J=7.94Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 120.11, 65.98, 40.23,
29.87, 13.09.

Synthesis of TBS protected alcohol trinitrile (5-6):
Alcohol trinitrile (9.70g), DMAP (5.77g, 1eq.), DIPEA (8.08mL, 1eq.), and dichloromethane
(50mL) were combined in a 500mL round bottom flask with a magnetic stir bar. TBS-OTf
(11.94mL, 1.1eq.) was added slowly to the flask and fuming was observed. A condenser with N2
inlet was quickly attached and the solution was refluxed for 48 hours. Solution was transferred to
separatory funnel and was washed with 1M HCl (3 x 25mL), 15% NaOH (2 x 10mL), brine (2 x
25mL), and H2O (1 x 25mL). The organic layer was dried with Na2SO4. Dichloromethane was
evaporated via rotovap and high vacuum to yield a white solid TBS protected alcohol trinitrile
(5.95g, 70% yield). 1H NMR (500 MHz, CDCl3) δ 3.38 (s, 2H), 2.35 (t, J=7.63Hz, 6H), 1.73 (t,
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J=8.24Hz, 6H), 0.90 (s, 9H), 0.08 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 117.67, 65.81, 39.40,
30.20, 26.57, 20.83, 12.65, -4.34.

Synthesis of TBS protected alcohol triamine (5-7):
TBS protected alcohol trinitrile (0.502g, 1eq.) was dissolved in a 250mL Erlenmeyer flask in
methanol (95mL) under gentle heating 40°C while stirring. Raney nickel (0.723g, 5.30eq) was
added to the solution. Solution was removed from heat and placed in an ice bath. Separately, a
solution of 8M NaOH (15mL) and NaBH4 (0.598g, excess) was prepared in a 100mL beaker. 8M
NaOH/NaBH4 solution was added into the Raney nickel/TBS protected alcohol trinitrile solution
in portions every 10 min over the course of 1 hour to maintain a reaction temperature of 60°C.
Solution effervesces upon addition. Once all NaBH4/NaOH was added, methanol (5mL) was
used to rinse the 100mL beaker to complete the transfer. Reaction solution was removed from
the ice bath once bubbling ceased and was heated in a warm water bath at 40°C for 72 hours to
ensure all nitrile groups were reduced. Upon completion, solution was transferred to a round
bottom flask and methanol was evaporated via rotovap. H2O (30mL) was added to the round
bottom flask. Solution was extracted with dichloromethane (3 x 50mL) and the organic extract
was dried with Na2SO4. Dichloromethane was evaporated via rotovap and high vacuum to yield
TBS protected alcohol triamine (0.450g, 86% conversion via NMR) as a yellow oil. 1H NMR
(500 MHz, CDCl3) δ 3.26 (s, 2H), 2.64 (t, J=7.01Hz, 6H), 1.33 (m, 7H, NH, CH2), 1.18 (m, 7H,
NH, CH2), 0.86 (s, 9H), 0.00 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 67.11, 45.00, 39.26, 32.97,
28.09, 25.84, 13.14, -5.68.
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